4//SEC Filing
McCann Corey 4
Accession 0001062993-23-001323
CIK 0001835567other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:06 PM ET
Size
7.5 KB
Accession
0001062993-23-001323
Insider Transaction Report
Form 4
McCann Corey
DirectorPresident and CEO
Transactions
- Sale
Class A Common Stock
2023-01-20$1.13/sh−34,731$39,246→ 8,210,834 total
Holdings
- 986,517(indirect: By Trust)
Class A Common Stock
- 1,685,913(indirect: By Trust)
Class A Common Stock
Footnotes (5)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.03 to $1.335, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- [F3]The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to these shares, except to the extent of his pecuniary interest therein.
- [F4]Shares held in The Corey M. McCann Irrevocable Trust of 2021. The trustee of The Corey M. McCann Irrevocable Trust of 2021 is Mia E. Moll.
- [F5]Shares held in The McCann Family Trust. The trustee of The McCann Family Trust is Concord Trust Company.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881049
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:06 PM ET
- Size
- 7.5 KB